IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia

BACKGROUND: The National Program for Chagas disease was implemented in Bolivia in 2006, and it greatly decreased the number of infections through vector control. Subsequently, a treatment regimen of benznidazole (BNZ) was started in seropositive school-age children living in certified vector control...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS Negl Trop Dis
Glavni autori: Vásquez Velásquez, Clara, Russomando, Graciela, Espínola, Emilio E., Sanchez, Zunilda, Mochizuki, Kota, Roca, Yelin, Revollo, Jimmy, Guzman, Angelica, Quiroga, Benjamín, Rios Morgan, Susana, Vargas Ortiz, Roberto, Zambrana Ortega, Alberto, Espinoza, Eida, Nishizawa, Juan Eiki, Kamel, Mohamed Gomaa, Kikuchi, Mihoko, Mizukami, Shusaku, Na-Bangchang, Kesara, Tien Huy, Nguyen, Hirayama, Kenji
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2019
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6760767/
https://ncbi.nlm.nih.gov/pubmed/31553732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0007715
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items